Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

MYSTERIOUS: Alzheimer association - You Need To See This

Congress Funded a $41.5 Million CDC Dementia Program That No Longer Has Any Staff Left to Run It

Congress appropriated $41.5 million for CDC Alzheimer's programs, but the agency staff who ran them were cut, leaving grantees without federal support.

Medical Daily

A $100 Million Trial Launched Today to Test Whether GLP-1 Drugs Plus Lifestyle Changes Can Prevent Dementia

Alzheimer's Association launched the $100M PROTECT-Cog Study July 13, 2026 in London to test GLP-1 drugs plus lifestyle changes as dementia prevention. First global trial of its kind.

Medical Daily

New Alzheimer’s Blood Test Leads To Early Detection And Treatment

A new Alzheimer’s blood test recently approved by the U. S. Food and Drug Administration (FDA) can now detect the disease in people with early...

Saving Advice

From analysis to the latest developments in health,
read the most diverse news in one place.

Alzheimer’s rates highest in Texas border counties, new study shows

Texas’ border counties have higher rates of Alzheimer’s disease among older adults than other areas in the state, according to a new study estimating county-level prevalence of the neurodegenerative disease.

Tribune News Service

Alzheimer’s report hints at a future health crisis bigger than COVID-19

The costs of Alzheimer’s disease – human and financial – are rising sharply in California and nationally, and census projections for America’s rapidly aging population suggest the scope of the disease soon might rival what America saw during the height of the COVID-19 pandemic.

The Orange County Register

Dementia care programs help, if caregivers can find them

There’s no cure, yet, for Alzheimer’s disease. But dozens of programs developed in the past 20 years can improve the lives of both people living with dementia and their caregivers.

Tribune News Service

Why a new Alzheimer's drug is having a slow US debut

The first drug to show that it slows Alzheimer’s is on sale, but treatment for most patients is still several months away

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Commentary: Too soon to celebrate new Alzheimer’s drug

A treatment that improves Alzheimer’s disease would be a great advance, but Leqembi (lecanemab), which recently received accelerated approval from the FDA, is not that drug. Yes, lecanemab slows decline to an extent detectable on a test, but not to an extent that a relative or caretaker would notice. This…

Tribune News Service

Why do some people get Alzheimer’s and others don’t? How a new tool checks your risk

Why do some people develop Alzheimer’s disease and others don’t? What makes one person’s brain healthier than another’s? And what can be done to improve, or at least slow, a brain’s deterioration?

Miami Herald

They live with Alzheimer's. Here's how they want to be treated during the holidays—in their own words

Living with Alzheimer's can feel isolating, especially during the holidays. Having support matters because "you can't fight this battle alone."

Fortune

Bud Harrelson’s family, teammates working to make sure nobody forgets about beloved former Met

NEW YORK — It was something so normal: Just two former teammates playing catch.

Tribune News Service

New Alzheimer's drug faces uncertain regulatory path

The FDA will soon decide whether to approve Eisai's experimental drug lecanemab.

Axios

Florida doctors use saliva test to reveal someone’s future risk for Alzheimer’s

Florida doctors are using a new test to determine someone’s future risk for Alzheimer’s disease from a few drops of spit.

Tribune News Service

For Alzheimer’s patients, a controversial drug brings hope

TAMPA, Fla. -- At 53, Michele Hall was at the height of her legal career. She’d just sent her three kids to college. She had decades ahead with her husband Doug — after nearly 30 years of marriage, the couple looked forward to celebrating 30 more.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Daily multi-vitamins may improve brain function in older people – US study

Trial finds supplements could slow decline by 60% but Alzheimer’s and dementia experts caution larger studies needed

The Independent UK

Taking multivitamins may protect against cognitive decline in over-65s – study

But researchers say more studies are needed to confirm the findings before health recommendations can be made.

WEKU

With early Alzheimer's in the family, these sisters decided to test for the gene

For some people, a rare genetic mutation makes dementia inescapable. Three sisters have decided to confront fate with a genetic test and have joined a research project on possible treatments.

Inverse

Alzheimer's disease has no cure — but unproven treatments claim otherwise

Frustrated by a lack of mainstream medical treatments, Alzheimer’s disease and dementia patients look to unproven alternatives that promise to end and reverse these incurable diseases.

Get all your
news in one place.

100's of premium titles.
One news app.

Chicago Sun-Times

Even simple exercise might help older people’s brains, new study suggests

The new study presented at the Alzheimer’s Association’s annual conference marks the longest test of whether exercise makes any difference once memory starts to slide.

Benzinga

LGVN: Alzheimer's Study Gains Traction as CEO Search Continues

By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT

Benzinga

LGVN: LGVN Publishes Positive Alzheimer's Results

By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

353 stories

the Food and Drug Administration

the Alzheimer Association

52 stories

STAT

51 stories

Alzheimer Association

21 stories

the National Institute on Aging

20 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.